BIRC5 and breast cancer: Kreger et al. [117] discovered that paclitaxel exposure caused breast cancer cells to generate survivin-containing exosomes, which strongly lengthened the survival of serum-starved and paclitaxel-treated fibroblasts and breast cancer cells.